If you are wondering whether IDEXX Laboratories is still fairly priced after a strong run, this article walks through what the current share price could mean for long term investors. The stock last ...

IDEXX Laboratories (NASDAQ:IDXX) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the ...

IDEXX Laboratories, Inc. (IDXX) is a multinational healthcare company specializing in the development, manufacture, and ...

IDEXX Laboratories, Inc.’s IDXX strong momentum in its CAG (Companion Animal Group) Diagnostics business places it well for growth in the upcoming quarters. It is also building its global commercial ...

IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40. The pet healthcare company reported sales of $954.3 million, ...

The humanization of pets megatrend should eventually power these stocks to new highs. Idexx Labs' expansion into oncology diagnostics for pets could reignite its decelerating sales growth. Zoetis' ...

Detailed price information for Idexx Laboratories (IDXX-Q) from The Globe and Mail including charting and trades.